Shanghai, China

Qian He

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 7.9

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2025

where 'Filed Patents' based on already Granted Patents

3 patents (USPTO):

Title: Innovations and Contributions of Inventor Qian He

Introduction

Qian He is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating neurodegenerative diseases and thrombotic disorders. With a total of three patents to his name, Qian He continues to impact the medical research landscape.

Latest Patents

Qian He's latest patents include the use of (5R,7R,10R)-12,15-dioxo-α-selinene in the preparation of drugs. This compound, known as PFC-37, is utilized in the development of a drug aimed at preventing and treating neurodegenerative diseases, including Parkinson's disease. Another significant patent is for a quaternary lactam compound, which is used in the manufacture of a medicament for the treatment and/or prevention of thrombotic or thromboembolic disorders.

Career Highlights

Throughout his career, Qian He has worked with esteemed institutions such as the Chinese Academy of Sciences and Shanghai Meiyue Biotech Development Co., Ltd. His work in these organizations has allowed him to advance his research and contribute to important medical innovations.

Collaborations

Qian He has collaborated with several professionals in his field, including Shanghai Yu and Yan Feng, who is a prominent female researcher. These collaborations have enriched his work and expanded the scope of his research.

Conclusion

Qian He is a distinguished inventor whose work has led to significant advancements in pharmaceutical research. His innovative patents and collaborations highlight his commitment to improving medical treatments and addressing critical health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…